As a part of the Reorganization plan recently approved by the House of Delegates, the Michigan State Medical Society (MSMS) Board of Directors is transitioning from 36 members to 13.
The House of Delegates passed bylaws changes that tasked a Nomination Committee to review and recommend a Board slate to membership. This is similar to the previous process when the county or region would nominate a Board member and the House would approve those recommendations.
After an open call to membership, MSMS received many outstanding applications and were highly impressed by the candidates’ qualifications and background. The Board of Directors Nominating Committee has carefully reviewed all applicants and has put forth a slate of recommended candidates based on exceptional qualifications, leadership experience, and dedication to our mission.
The Board of Directors Nominating Committee recommends the following slate for the 2026-2027 Board of Directors. As the President and President Elect were already elected by previous House of Delegates, the recommended slate is for 11. Members are able to vote for all 11, or a number less than. Initial term limits will be staggered. One-, two- and three-year terms will be determined by vote counts. Voting will remain open from July 13 – July 25, 2026.
- Bradley Uren, MD, Chair
- Leah Davis, DO, Vice Chair
- John Waters, MD, Treasurer/Secretary
- Lou Edje, MD
- Robert Flora, MD
- Bryan Huffman, MD
- Courtland Keteyian, MD
- Mark Komorowski, MD
- Latonya Riddle Jones, MD
- Danial Ryan, MD
- Amit Sachdev, MD
Vote Here: https://www.surveymonkey.com/r/MSMSBOARD2026
To view their applications, visit here.
As members of the Board of Directors, they will play a vital role in shaping the strategic direction and future success of MSMS. The Nominating Committee is truly appreciative of the time and effort members invested in applying. They encourage all members to continue to be engaged in all the important work of MSMS. Learn more here.
MSMS also thanks the Nominating Committee for their difficult work in reviewing, evaluating and recommending Board members to ably serve the organization during this important transition under reorganization: Paul D. Bozyk, MD; Richard E. Burney, MD; Leah C. Davis, DO; Amit Ghose, MD; Annette M. Gilmer, MD; Dennis M. Ramus, MD; Bradley J. Uren, MD; John A. Waters, MD; and Phillip G. Wise, MD.
Please note, the timeline for Board nominations was abbreviated in order to limit the period the association was without a full Board of Directors. In future years, more time will be available for nominations and member voting. For more information on MSMS reorganization efforts, please contact Rebecca Blake at 517-336-5729 or rblake@msms.org.